6-hydroxymelatonin has been researched along with Kidney Diseases in 1 studies
6-hydroxymelatonin : A member of the class of tryptamines that is melatonin with a hydroxy group substituent at position 6.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, M | 1 |
| Yoshida, M | 1 |
| Nishijima, H | 1 |
| Yokosuka, M | 1 |
| Iigo, M | 1 |
| Ohtani-Kaneko, R | 1 |
| Shimada, A | 1 |
| Hasegawa, T | 1 |
| Akama, Y | 1 |
| Hirata, K | 1 |
1 other study available for 6-hydroxymelatonin and Kidney Diseases
| Article | Year |
|---|---|
Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats.
Topics: Animals; Antineoplastic Agents; Antioxidants; Blood Urea Nitrogen; Cisplatin; Creatinine; Free Radic | 2001 |